Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2465 posts found.

Foghorn Therapeutics appoints Alfonso Quintás-Cardama as new chief medical officer

August 18, 2023 Business Services Alfonso Quintas-Cardama, Foghorn Therapeutics, Haematology, chief medical officer

The biotechnology company Foghorn Therapeutics has announced the addition of the new chief medical officer, Alfonso Quintás-Cardama, who will be …

Sunbird Bio and Glympse Bio merge for development of protein-based diagnostic technology

August 10, 2023 Business Services Glympse Bio, Oncology, Sunbird Bio, merger, oncology

Sunbird Bio has announced that it has completed a merger with Glympse Bio, intending to accelerate the development of both …

Astellas set to open new life sciences facilities in Cambridge, Massachusetts

August 10, 2023 Business Development Astellas Pharma, Pharmacy, pharmaceutical, science facility

On 9 August 2023, Astellas Pharma announced its plans to open what it has described as a “state-of-the-art life sciences …

EureKING planning creation of new biotech company through the acquisition of SCTbio

August 9, 2023 Business Services, Research and Development Pharmacy

On 9 August 2023, eureKING announced it is set to acquire the pharmaceutical company SCTbio which specializes in cell and …

Astex expands collaboration with MSD

August 8, 2023 Business Services Astex pharmaceuticals, Merck, Oncology, collaboration, small molecules

Astex Pharmaceuticals has announced an exclusive worldwide research collaboration and license agreement with MSD (known as Merck in the US), …

Ionis and Novartis partner for CVD treatment programme

August 4, 2023 Business Services Cardiology, Ionis Pharmaceuticals, License Agreement, Novartis, cvd

Ionis Pharmaceuticals has announced that it has entered into a new collaboration and license agreement with Novartis, aiming to discover, …

Biogen to acquire Reata Pharmaceuticals

July 31, 2023 Business Services Biogen, Neurology, Reata Pharmaceuticals, acquisition

Biogen and Reata Pharmaceuticals have announced that they have entered a definitive agreement under which Biogen will acquire Reata for …

Renibus Therapeutics announces $47m financing for phase 3 trial

July 19, 2023 Business Services Cardiology, Financing, Renibus Therapeutics, clinical trial

Clinical stage biopharmaceutical company Renibus Therapeutics has announced that it has raised $47m from the initial closing of its Series …

Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies

July 18, 2023 Business Services Inizio Engage, Patient Access Services, Pharmacy, patient support

Fort Washington, US — Inizio Engage is pleased to announce the launch of Patient Access Services. This custom-built, integrated suite of patient support services …

CellCentric announces $25m investment from Pfizer

July 12, 2023 Business Services Cancer, CellCentric, Oncology, Pfizer, collaboration, investment

UK-based biotechnology company CellCentric has announced a strategic investment from Pfizer including $25m to finance further development of inobrodib, its …

Roger Dmochowski appointed as Versameb’s chief medical officer

July 5, 2023 Business Services Roger Dmochowski, Urology, Versameb, appointment, chief medical officer

Versameb AB has announced the appointment of Professor Roger Dmochowski as chief medical officer. Dmochowski is a renowned researcher and …

Cytovation appoints Olav Hellebø to board of directors

July 5, 2023 Business Services Cytovation, Olav Hellebø, Oncology, appointment, board of directors

Cytovation ASA, a clinical stage immune-oncology company with a focus on targeted tumour membrane immunotherapies, has announced that it has …

Croda International acquires Solus Biotech

July 4, 2023 Business Services Croda International, Pharmacy, Solus Biotech, acquisition

Croda International has confirmed that it has successfully acquired Solus Biotech, following receipt of approval from the South Korean regulatory …

Josef Penninger appointed as new scientific director of Helmholtz Centre for Infection Research

July 3, 2023 Business Services Helmholtz Centre for Infection Research, Josef Penninger, appointment, scientific director

The Helmholtz Centre for Infection Research (HZI), Germany, has appointed Professor Josef Penninger as scientific director. Penninger has previously worked …

Kevin Hawkins appointed as Reacta’s head of regulatory affairs

July 3, 2023 Business Services Kevin Hawkins, Reacta, appointment, head of regulatory affairs

Reacta Healthcare, an early-stage food allergy diagnostic company, has announced the appointment of Kevin Hawkins as head of regulatory affairs. …
The Gateway to Local Adoption Series

Latest content